Stroke and Vascular Neurology

Papers
(The median citation count of Stroke and Vascular Neurology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
MetS in the prediction of asymptomatic intracranial arterial stenosis: the potential mediating role of hsCRP245
Photochemically induced thalamus infarction impairs cognition in a mouse model82
Oxidised low-density lipoprotein and adverse outcome in patients with acute mild ischaemic stroke or high-risk TIA: a secondary analysis of the INSPIRES randomised clinical trial60
Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospe51
Prediction of futile recanalisation after endovascular treatment in acute ischaemic stroke: development and validation of a hybrid machine learning model48
Efficacy of immediate anti-hypertensive treatment in patients with acute ischaemic stroke stratified by mean arterial pressure and pulse pressure: a secondary analysis of the China Antihypertensive Tr40
Multiomics genetic insights into potential molecular targets for intracranial aneurysm36
Dural sinus septum: an underlying cause of cerebral venous sinus stenting failure and complications34
Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease31
Mechanical thrombectomy with combined stent retriever and contact aspiration versus stent retriever alone for acute large vessel occlusion: data from ANGEL-ACT registry31
Acute right insular ischaemic lesions and poststroke left ventricular dysfunction29
Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial29
Stepwise improvement in intracerebral haematoma expansion prediction with advanced imaging: a comprehensive comparison of existing scores29
KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway27
Characteristics, temporal trends and outcomes of intravenous thrombolysis in Chinese patients aged>80 years who had a stroke26
Would integrated Western and traditional Chinese medicine have more benefits for stroke rehabilitation? A systematic review and meta-analysis23
Detailed phenotype ofRNF213p.R4810K variant identified by the Chinese patients with acute ischaemic stroke or transient ischaemic attack22
Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study21
Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial21
Frequency, predictors and cardiovascular outcomes associated with transthoracic echocardiographic findings during acute ischaemic stroke hospitalisation21
Pipeline Embolization Device for intracranial aneurysms presenting with mass effect: a large Chinese cohort20
LRRC8A in endothelial cells contributes to the aberrant blood-brain barrier integrity in ischaemic stroke20
Thrombus migration in patients with acute ischaemic stroke undergoing endovascular thrombectomy19
Poststroke motor, cognitive and speech rehabilitation with brain–computer interface: a perspective review18
Angioarchitecture and prognosis of pediatric intracranial pial arteriovenous fistula18
Endovascular treatment for basilar artery occlusion: a meta-analysis18
Linking the Paul Coverdell National Acute Stroke Program to commercial claims to establish a framework for real-world longitudinal stroke research18
Call for emergency action to limit global temperature increases, restore biodiversity and protect health17
Discontinuation of antiplatelet therapy after stent-assisted coil embolisation of cerebral aneurysm: a nationwide cohort study17
Arteriolosclerosis differs from venular collagenosis in relation to cerebrovascular parenchymal damages: an autopsy-based study17
Effect of haemodynamics on the risk of ischaemic stroke in patients with severe vertebral artery stenosis17
Treatment with intravenous alteplase in ischaemic stroke patients with onset time between 4.5 and 24 hours (HOPE): protocol for a randomised, controlled, multicentre study16
Ten-year follow-up investigation of stroke risk in systemic lupus erythematosus16
CCL17 exerts neuroprotection through activation of CCR4/mTORC2 axis in microglia after subarachnoid haemorrhage in rats16
Enhanced diagnostic workup increases pathological findings in patients with acute ischaemic stroke: results of the prospective HEBRAS study15
Low LDL-C level and intracranial haemorrhage risk after ischaemic stroke: a prospective cohort study15
STING mediates microglial pyroptosis via interaction with NLRP3 in cerebral ischaemic stroke15
Cerebrovascular cinematic rendering of multisystemic smooth muscle dysfunction syndrome14
Quantitative histopathological analysis of thrombi retrieved by mechanical thrombectomy and their association with stroke aetiology13
Src inhibition rescues FUNDC1-mediated neuronal mitophagy in ischaemic stroke13
Endovascular therapy in acute anterior circulation large vessel occlusive patients with a large infarct core (ANGEL-ASPECT): protocol of a multicentre randomised trial13
Childhood strokes in China describing clinical characteristics, risk factors and performance indicators: a case-series study13
Extracellular vesicles bearing serum amyloid A1 exacerbate neuroinflammation after intracerebral haemorrhage13
Racial disparities in access to, and outcomes of, acute ischaemic stroke treatments in the USA13
Baseline systolic blood pressure and efficacy of dual antiplatelet in acute ischaemic stroke12
Incidence and predictors of futile recanalisation after endovascular therapy in acute vertebrobasilar artery occlusion patients: insight from the ANGEL-ACT registry12
Thrombolytic agents, more options, more challenges12
Development, validation and comparison of multivariable risk scores for prediction of total stroke and stroke types in Chinese adults: a prospective study of 0.5 million adults11
Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to impro11
Sex differences in the epidemiology of spontaneous and traumatic cervical artery dissections11
Central post-stroke pain: advances in clinical and preclinical research11
Dual regulation of Atf3 and Lonp1 as therapeutic targets in cerebral ischaemia-reperfusion injury11
Mobile stroke care expedites intravenous thrombolysis and endovascular thrombectomy11
Retrograde recanalisation for vertebral artery stump syndrome: a case report11
Cerebral haemodynamics in symptomatic intracranial atherosclerotic disease: a narrative review of the assessment methods and clinical implications10
Definitions of white matter hyperintensity change: impact on estimates of progression and regression10
Rationale and design of Low-Frequency REpetitive TRanscranial Magnetic Stimulation Combined with Endovascular Treatment in ACute Ischaemic StrokE (RETRACE II): a randomised double-blind controlled mul10
Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study10
Inflammatory biomarkers and cerebral small vessel disease: a community-based cohort study10
Advance Consent for participation in Acute Stroke Trials (ACTION): protocol for a feasibility study10
Prediction of large vessel occlusion for ischaemic stroke by using the machine learning model random forests10
Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion10
DRug-coated Balloon for Endovascular treatment of sYmptOmatic intracraNial stenotic Disease (DR. BEYOND): the protocol of a multicentre randomised trial10
Exosomes-mediated delivery of miR-486-3p alleviates neuroinflammation via SIRT2-mediated inhibition of mitophagy after subarachnoid hemorrhage9
CSA declaration of next-generation reperfusion therapy for ischaemic stroke9
Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: a randomised, double-blind, placebo-controlled clinical trial9
Surgical timing and long-term outcomes in patients with severe haemorrhagic spinal cord cavernous malformations9
Oestrogen ameliorates blood-brain barrier damage after experimental subarachnoid haemorrhage via the SHH pathway in male rats9
Comparison of the Pipeline embolisation device alone or combined with coiling for treatment of different sizes of intracranial aneurysms9
Loss of life expectancy due to stroke and its subtypes in urban and rural areas in China, 2005–20209
Efficacy of butylphthalide in preventing cognitive decline in ischaemic stroke survivors: a 12-month prospective following-up study9
Exploring the relationship between embolic acute stroke distribution and supra-aortic vessel patency: key findings from an in vitro model study9
Cisternostomy for malignant middle cerebral artery infarction: proposed pathophysiological mechanisms and preliminary results9
Effect of intravenous alteplase before endovascular therapy for atherothrombotic stroke-related large vessel occlusion: subanalysis of the RESCUE AT-LVO registry8
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-8
Improving detection of cerebral small vessel disease aetiology in patients with isolated lobar intracerebral haemorrhage8
Why non-human primates are needed in stroke preclinical research8
Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design8
Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects8
Intra-arterial thrombolytics during endovascular thrombectomy for acute ischaemic stroke in the MR CLEAN Registry8
Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy8
COP27 climate change conference: urgent action needed for Africa and the world8
Somatic mutation contributing to clonal haematopoiesis is a risk factor of recurrent stroke in first-ever acute ischaemic stroke: a prospective cohort study8
Correction:Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)8
Young stroke in Bangladesh: addressing rare cases with diagnostic challenges and much-needed solutions8
Dl-3-n-butylphthalide attenuates brain injury caused by cortical infarction accompanied by cranial venous drainage disturbance8
Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study8
Real-world analysis of two ischaemic stroke and TIA systolic blood pressure goals on 12-month mortality and recurrent vascular events8
Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases8
Haemorrhage after thrombectomy with adjuvant thrombolysis in unknown onset stroke depends on high early lesion water uptake7
Predictors of futile recanalisation in patients with large infarct: a post-hoc analysis of the ANGEL-ASPECT trial7
Microsurgical treatment of posterior inferior cerebellar aneurysms based on angioarchitecture supplemented by high-resolution vessel wall MRI: a case series report7
Associations of accelerated biological ageing with incident dementia, cognitive functions and brain structure: a prospective cohort study based on UK Biobank7
Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study7
Model based on single-nucleotide polymorphism to discriminate aspirin resistance patients7
VasCog Screen test: sensitive in detecting cognitive impairment in patients who had a stroke or with heart failure7
Correlation of enlarged perivascular spaces in basal ganglion and cancer-associated stroke: a case–control study in China7
Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trial7
Paediatric intracranial dural arteriovenous fistulas: clinical characteristics, treatment outcomes and prognosis6
Is intraprocedural intravenous aspirin safe for patients who require emergent extracranial stenting during mechanical thrombectomy?6
Application of bedside HINTS, ABCD2score and truncal ataxia to differentiate cerebellar–brainstem stroke from vestibular neuritis in the emergency room6
Intra-arterial tenecteplase during thrombectomy for acute stroke (BRETIS-TNK II): rationale and design6
In patients who had a stroke or TIA, enlarged perivascular spaces in basal ganglia may cause future haemorrhagic strokes6
Isolated anterior cerebral artery occlusion: an atypical form of moyamoya disease6
PRCP is a promising drug target for intracranial aneurysm rupture supported via multi-omics analysis6
Thrombolysis of stroke mimics via telestroke6
LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA6
Multicentre prospective, randomised open-label, endpoint-blinded study to evaluate the safety and efficacy of propranolol for the prevention of stroke-associated pneumonia in patients with intracerebr6
Roles of light transmission aggregometry and CYP2C19 genotype in predicting ischaemic complications during interventional therapy for intracranial aneurysms6
Rationale and design of a stepped wedge cluster randomised trial to improve acute reperfusion treatment quality for stroke: IMPROVE stroke care in China6
Long-term outcome in a cohort of 36 patients with sacral dural arteriovenous fistulae after endovascular embolisation or microsurgery6
Clinical outcomes of endovascular interventions for cerebral venous thrombosis in Japan: a nationwide retrospective study6
Association between Life’s Essential 8 and Cerebral Small Vessel Disease6
Functional status at 30 and 90 days after mild ischaemic stroke6
Risk factors for carotid plaque progression after optimising the risk factor treatment: substudy results of the Atherosclerotic Plaque Characteristics Associated with a Progression Rate of the Plaque 6
0.23-Tesla MRI to differentiate between ischaemic and haemorrhagic strokes within 24 hours of onset: a combined experimental–clinical study5
Bone marrow-derived mesenchymal stem cell ameliorates post-stroke enterobacterial translocation through liver-gut axis5
Asymptomatic carotid artery stenosis is associated with increased Alzheimer’s disease and non-Alzheimer’s disease dementia risk5
Chinese Stroke Association guidelines on emergency stroke unit5
Protective effects of melatonin on stroke in diabetic mice: central and peripheral inflammation modulation5
Predictors of malignant swelling in space-occupying cerebellar infarction5
Association of fluid balance with 3-month outcomes in severe acute ischaemic stroke5
Comparing the effectiveness and safety of rescue balloon angioplasty versus stenting in acute large vessel occlusion after thrombectomy5
Time to treat the climate and nature crisis as one indivisible global health emergency5
New rat model of spinal cord infarction with long-lasting functional disabilities generated by intraspinal injection of endothelin-15
Distribution and prognosis of acute ischaemic stroke with negative diffusion-weighted imaging5
Comparing a novel Catfish flow restoration device and the Solitaire stent retriever for thrombectomy revascularisation in emergent largevessel occlusion stroke: a prospective randomised controlled stu5
Rationale and design of Treatment of Acute Ischaemic Stroke with Edaravone Dexborneol II (TASTE-2): a multicentre randomised controlled trial5
Should patients with minor strokes be given thrombolytics?5
Intracerebral haemorrhage laterality and associations with mood and pain: a MISTIE III substudy5
CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke Tenecteplase II (CHABLIS-T II): rationale and design5
Prevalence and risk factors of stroke in China: a national serial cross-sectional study from 2003 to 20185
Risk stratification in symptomatic intracranial atherosclerotic disease with conventional vascular risk factors and cerebral haemodynamics5
Pictures of stroke and cerebral vasculature: novel insights and detailed visualisation of U-shaped elastin distribution and disorganised fibre arrangement at carotid bifurcations by advanced technique5
Anaesthesia modality on endovascular therapy outcomes in patients with large infarcts: a post hoc analysis of the ANGEL-ASPECT trial5
Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial5
Stenting for symptomatic intracranial arterial stenosis with different qualifying arteries: a preplanned pooled individual patient data analysis4
Association of APOE genotype with CT markers of cerebral amyloid angiopathy in spontaneous intracerebral haemorrhage4
Vascular dementia has the highest hospitalisation rate in China: a nationwide hospital information system study4
ADVISING score: a reliable grading scale based on injury and response for intracerebral haemorrhage4
Prominent juxtacortical white matter lesion hallmarksNOTCH3-related intracerebral haemorrhage4
MALAT1 promotes platelet activity and thrombus formation through PI3k/Akt/GSK-3β signalling pathway4
Response to ‘comments on the article ‘sex differences in the epidemiology of spontaneous and traumatic cervical artery dissections’’4
Intelligent cholinergic white matter pathways algorithm based on U-net reflects cognitive impairment in patients with silent cerebrovascular disease4
Peripheral bloodGATA2expression impactsRNF213mutation penetrance and clinical severity in moyamoya disease4
Long-term functional outcomes improved with deep brain stimulation in patients with disorders of consciousness4
Determinants of prehospital and in-hospital delay in patients with symptomatic carotid stenosis and their influence on the outcome after elective carotid endarterectomy4
China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Dise4
Magnitude of systolic blood pressure reduction following endovascular treatment and clinical outcomes in acute large artery occlusion stroke4
Gut Microbiome and Stroke: a Bidirectional Mendelian Randomisation Study in East Asian and European Populations4
Phase II randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of MLC1501 in patients with stroke: the MLC1501 study Assessing Efficacy in post-STrOke Subjects with mOto4
Residual inflammatory risk predicts long-term outcomes following stenting for symptomatic intracranial atherosclerotic stenosis4
Characterising acute ischaemic stroke thrombi: insights from histology, imaging and emerging impedance-based technologies4
When treating acute ischaemic stroke of LVO type, time window prevails over tissue window3
Association of fluid-attenuated inversion recovery vascular hyperintensity with ischaemic events in internal carotid artery or middle cerebral artery occlusion3
Altered excitability of motor neuron pathways after stroke: more than upper motor neuron impairments3
Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis (BASIS): protocol of a prospective, multicentre, randomised, controlled trial3
Left atrial appendage closure in patients with atrial fibrillation and acute ischaemic stroke despite anticoagulation3
Endovascular thrombectomy with or without intravenous alteplase for acute ischemic stroke due to large vessel occlusion: a systematic review and meta-analysis of randomized trials3
Dual antiplatelet therapy with ticagrelor may increase the risk of all bleeding events in patients with minor strokes or high risk TIAs: a meta-analysis3
Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial3
Precision antiplatelet therapy for the prevention of ischaemic stroke3
Influence of impaired renal function on the outcomes of patients with acute ischaemic stroke treated with intravenous tenecteplase and alteplase: a post hoc analysis of the TRACE-2 trial3
AHORA: a Spanish language tool to identify acute stroke symptoms3
Clinician’s perspectives in using head impulse-nystagmus-test of skew (HINTS) for acute vestibular syndrome: UK experience3
Prestroke physical activity is associated with admission haematoma volume and the clinical outcome of intracerebral haemorrhage3
Retinal microvascular signs and recurrent vascular events in patients with TIA or minor stroke3
Where are we going for the treatment in ischaemic stroke: a comprehensive study of investigator-sponsored randomised controlled trials, 1990–20243
Dual antiplatelet therapy with ticagrelor vs clopidogrel in patients with TIA or minor stroke with or without symptomatic carotid artery stenosis: a post hoc analysis of the CHANCE-2 trial3
Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials3
Efficacy and safety of a neurointerventional operation robotic assistance system in cerebral angiography3
Prospective, multicentre study of screening, investigation and management of hyponatraemia after subarachnoid haemorrhage in the UK and Ireland3
Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2)3
Antiplatelet therapy versus intravenous thrombolysis for mild acute ischaemic stroke: a living systematic review and meta-analysis3
Neglected Mendelian causes of stroke in adult Chinese patients who had an ischaemic stroke or transient ischaemic attack3
Characteristics of intracranial plaque in patients with non-cardioembolic stroke and intracranial large vessel occlusion3
Venous thromboembolism among Medicare acute ischaemic stroke patients with and without COVID-193
Circulating immune cell landscape in patients who had mild ischaemic stroke3
Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats3
White matter hyperintensity progression is associated with incident probable dementia or mild cognitive impairment3
0.039143085479736